Ward Scott R. 4

What Happened
Scott R. Ward, a director of InspireMD, purchased a total of 89,250 shares of InspireMD stock in two open-market transactions: 15,995 shares on 2026-05-06 at a weighted average price of $1.15 ($18,394) and 73,255 shares on 2026-05-07 at a weighted average price of $1.15 ($84,243). Combined consideration for the purchases was approximately $102,637. This was a purchase (buy), which investors often view as a more informative action than routine sales.

Key Details

• Transaction type: P = Purchase (open market/private purchase)
• Dates and reported prices: May 6, 2026 — 15,995 sh @ $1.15 ($18,394); May 7, 2026 — 73,255 sh @ $1.15 ($84,243)
• Combined total: 89,250 shares for ~$102,637
• Footnote: Reported price is a weighted average; actual trade prices ranged from $1.13 to $1.15. The reporting person will provide a breakdown of shares at each price upon request (Footnote F1).
• Shares owned after transaction: Not specified in the filing
• Filing: Report filed 2026-05-08 — appears timely (Form 4 is generally due within two business days)

Context
This filing reports straightforward open-market purchases by a company director (not an option exercise, grant, or gift). The filing includes an Exhibit 24.1 power of attorney remark. The purchase itself is factual information; it does not explain the director’s motives.